CBD Therapeutic Benefits
The World Health Organization published a report on CBD in November of 2017. Below is an overview in which CBD may have therapeutic benefits.
Disease |
Effects |
Alzheimer's disease |
Antinflammatory, antioxidant, antiapoptotic in in vitro and in vivo models |
Parkinson's disease |
Attenuation of the dopaminergic impairment in vivo; neuroprotection; improvement of psychiatric rating and reduction of agitation, nightmare |
Multiple sclerosis |
Improved signs of EAE in mice, antinflammatory and immunomodulatory |
Huntington's |
Neuroprotective and antioxidant in mice transgenic models; no significant |
Hypoxia-ischemia |
Short term neuroprotective effects; inhibition of excitotoxicity, oxidative |
Pain |
Analgesic effect in patients with neuropathic pain resistant to other |
Psychosis |
Attenuation of the behavioural and glial changes in animal models of |
Anxiety |
Reduction of muscular tension, restlessness, fatigue, problems in concentration, improvement of social interactions in rodent models of |
Depression |
Anti-depressant effect in genetic rodent model of depression. |
Cancer |
Antiproliferative and anti-invasive actions in a large range of cancer types; |
Nausea |
Suppression of nausea and conditioned gaping in rats |
Inflammatory |
Antinflammatory properties in several in vitro and in vivo models; |
Rheumatoid |
Inhibition of TNF-α in an animal model |
Infection |
Activity against methicillin-resistant Staphylococcus aureus |
Inflammatory bowel and Crohn's |
Inhibition of macrophage recruitment and TNF-α secretion in vivo and ex vivo; reduction in disease activity index in Crohn's patients. |
Cardiovascular |
Reduced infarct size through anti-oxidant and anti-inflammatory |
Diabetic |
Attenuation of fibrosis and myocardial dysfunction |
For more about the paper, please click here